Coverart for item
The Resource Big pharma and drug pricing, Pete Schauer, book editor

Big pharma and drug pricing, Pete Schauer, book editor

Label
Big pharma and drug pricing
Title
Big pharma and drug pricing
Statement of responsibility
Pete Schauer, book editor
Title variation
  • Opposing viewpoints
  • Big pharma and drug pricing
Title variation remainder
  • big pharma and drug pricing
  • opposing viewpoints
Contributor
Editor
Subject
Genre
Language
eng
Summary
Americans pay among the highest prices for prescription drugs, thanks to government legislation and the powerful pharmaceutical lobbies. The effect has been disastrous, with many citizens obtaining cheaper medicine from Canada, and others forgoing it altogether at the risk of their health. These crippling prices are set by "big pharma," at the insistence of those who support free trade. Consumers call the pharmaceutical companies greedy and selfish, but these companies also enact change, through scientific research, curing of diseases, and community outreach. What is the answer to this complex issue? Readers will learn about the conflicts and potential solutions in this compelling volume
Member of
Cataloging source
DLC
Dewey number
338.4/361510973
Index
index present
Intended audience
Grade 9 to 12
LC call number
HD9665.4
LC item number
.S33 2018
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorName
Schauer, Pete
Series statement
  • Opposing viewpoints
  • Opposing viewpoints series Unnumbered
http://library.link/vocab/subjectName
  • Drugs
  • Prescription pricing
  • Pharmaceutical industry
  • Drugs
  • Drugs
  • Drugs
  • Pharmaceutical industry
  • Prescription pricing
  • United States
  • United States
Target audience
adolescent
Label
Big pharma and drug pricing, Pete Schauer, book editor
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Introduction -- Why are prescription drugs so expensive? -- The truth behind the high costs of prescription drugs / Julie Appleby -- Higher education plays an important role in the pharma industry / Annie Waldman -- Patent laws keep drug prices high / Matthew Rimmer -- Market exclusivity delays the availability of cheaper generic drugs / Zachary Brennan -- Drug prices are high for legitimate reasons / Michael Rosenblatt, MD -- Why don't insurance companies cover all prescription drugs? -- Government-protected monopolies drive drug prices higher / Sydney Lupkin -- Consumers are caught in the middle when the interests of drug companies and insurers conflict / Alison Kodjak -- Employers should use their power to cut drug prices / Robert Galvin, MD, Roger Longman -- Lowering drug prices may mean switching medications / Alison Kodjak -- "Medically necessary" drugs are increasing prices overall / Marcelle Arak and Sheila Tschinkel
  • What are the ethics behind charging astronomical prices for prescription drugs? -- The ethics of pharmaceutical benefit management are blurry / Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel -- Americans spend more on prescriptions than most other countries / Steve Morgan and Jae Kennedy -- Nothing stops drug companies from charging the highest market price / AARP -- Encouraging competition is the answer to affordable pharmaceuticals / Charles L. Hooper and David R. Henderson -- Prescription demand is why Americans pay so much for drugs / Valerie Paris -- Will we see legislative changes to the way drugs are priced? -- Government reforms can address consumer concerns / Rachel Sachs -- Big pharma has too much influence over politicians / Mike Ludwig -- Transparency bills are the key to lowering drug prices / Michael Ollove -- It's time to rein in exorbitant pharmaceutical prices / Rafi Mohammed -- The government doesn't deserve the blame for high drug prices / David Blumenthal, M.D. and David Squires -- Pharma companies game the system to keep drugs expensive / Erin Fox
Dimensions
23 cm.
Extent
208 pages
Isbn
9781534501768
Lccn
2017036789
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
ocn999672117
Label
Big pharma and drug pricing, Pete Schauer, book editor
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Introduction -- Why are prescription drugs so expensive? -- The truth behind the high costs of prescription drugs / Julie Appleby -- Higher education plays an important role in the pharma industry / Annie Waldman -- Patent laws keep drug prices high / Matthew Rimmer -- Market exclusivity delays the availability of cheaper generic drugs / Zachary Brennan -- Drug prices are high for legitimate reasons / Michael Rosenblatt, MD -- Why don't insurance companies cover all prescription drugs? -- Government-protected monopolies drive drug prices higher / Sydney Lupkin -- Consumers are caught in the middle when the interests of drug companies and insurers conflict / Alison Kodjak -- Employers should use their power to cut drug prices / Robert Galvin, MD, Roger Longman -- Lowering drug prices may mean switching medications / Alison Kodjak -- "Medically necessary" drugs are increasing prices overall / Marcelle Arak and Sheila Tschinkel
  • What are the ethics behind charging astronomical prices for prescription drugs? -- The ethics of pharmaceutical benefit management are blurry / Stephan L. Burton, Lauren Randel, Karen Titlow, and Ezekiel J. Emanuel -- Americans spend more on prescriptions than most other countries / Steve Morgan and Jae Kennedy -- Nothing stops drug companies from charging the highest market price / AARP -- Encouraging competition is the answer to affordable pharmaceuticals / Charles L. Hooper and David R. Henderson -- Prescription demand is why Americans pay so much for drugs / Valerie Paris -- Will we see legislative changes to the way drugs are priced? -- Government reforms can address consumer concerns / Rachel Sachs -- Big pharma has too much influence over politicians / Mike Ludwig -- Transparency bills are the key to lowering drug prices / Michael Ollove -- It's time to rein in exorbitant pharmaceutical prices / Rafi Mohammed -- The government doesn't deserve the blame for high drug prices / David Blumenthal, M.D. and David Squires -- Pharma companies game the system to keep drugs expensive / Erin Fox
Dimensions
23 cm.
Extent
208 pages
Isbn
9781534501768
Lccn
2017036789
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
ocn999672117

Library Locations

    • Kasson-Mantorville High SchoolBorrow it
      101 16th St. NE, Kasson, MN, 55944, US
      44.0439275 -92.7475412

Library Links

Processing Feedback ...